Novel Targets and Tools for the Treatment of Cardiovascular Disease
Therapeutic Potential of CCN5 (WISP-2) Following
Vascular Injury
John Castellot
Insights into Microvascular Remodeling During Development and Disease
Ira Herman
Dissection of a Proinflammatory Signaling Pathway: Potential Implications for Atherosclerosis
John Kyriakis
Pepducins, a Novel Class of GPCR Antagonists for the Treatment of Cardiovascular Diseases
Andrew Leger
Moderated by Martin Beinborn
Jean Mayer USDA Human Nutrition Research Center on Aging Auditorium
711 Washington Street, Boston |